World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Chemistry 52 13653 12293 768 682 162 8342
Biology and Biochemistry 51 17287 15867 1356 1254 145 8147

Michael Rowley publications per year

The chart shows the history of publications by Michael Rowley between 1985 and 2023, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Michael Rowley published across 39 years, from 1985 to 2023, averaging 4.5 papers a year. Output peaked at 22 publications in 2009. 3 of the 175 publications appeared in the last two years.

No. of publications
5 10 15 20
Bar chart. Horizontal axis: year, 1985 to 2023. Vertical axis: number of publications, 0 to 22. Peak 22 publications in 2009. 1985: 1 publication 1986: 4 publications 1987: 1 publication 1988: 1 publication 1989: 3 publications 1990: 1 publication 1991: 3 publications 1992: 8 publications 1993: 6 publications 1994: 6 publications 1995: 3 publications 1996: 7 publications 1997: 3 publications 1998: 10 publications 1999: 8 publications 2000: 12 publications 2001: 5 publications 2002: 2 publications 2003: 3 publications 2004: 5 publications 2005: 8 publications 2006: 4 publications 2007: 5 publications 2008: 12 publications 2009: 22 publications 2010: 9 publications 2011: 7 publications 2012: 7 publications 2013: 1 publication 2014: 1 publication 2015: 1 publication 2016: 0 publications 2017: 0 publications 2018: 0 publications 2019: 3 publications 2020: 0 publications 2021: 0 publications 2022: 1 publication 2023: 2 publications
1985 2023

175 publications in total across all disciplines

View publications per year as a table
Michael Rowley: publications per year, 1985 to 2023
Year Publications
1985 1
1986 4
1987 1
1988 1
1989 3
1990 1
1991 3
1992 8
1993 6
1994 6
1995 3
1996 7
1997 3
1998 10
1999 8
2000 12
2001 5
2002 2
2003 3
2004 5
2005 8
2006 4
2007 5
2008 12
2009 22
2010 9
2011 7
2012 7
2013 1
2014 1
2015 1
2016 0
2017 0
2018 0
2019 3
2020 0
2021 0
2022 1
2023 2
Total 175
Download as CSV

Michael Rowley publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Michael Rowley sits on this spectrum.

No. of scientists
250 500 750 1,000 1,250
Bar chart with 63 bars. Horizontal axis: publications, 61–80 to 1,295+. Vertical axis: number of scientists, 0 to 1,350. Most scientists, 1,350, have 161–180 publications. The last bar groups every scientist with 1,295 publications or more. The highlighted bar, 161–180 publications, is where this scientist sits. 61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61–80 publications 1,295+

This scientist: 162 publications — 18th percentile

18% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

View publications distribution as a table
Number of Chemistry scientists by publication count, Research.com 2026 ranking edition. Based on 17,934 ranked scientists.
Publications Scientists This scientist
61–80 66
81–100 302
101–120 623
121–140 918
141–160 1,218
161–180 1,350 162
181–200 1,344
201–220 1,281
221–240 1,216
241–260 1,100
261–280 979
281–300 939
301–320 764
321–340 643
341–360 628
361–380 522
381–400 459
401–420 397
421–440 327
441–460 270
461–480 265
481–500 252
501–520 201
521–540 185
541–560 148
561–580 148
581–600 132
601–620 114
621–640 104
641–660 91
661–680 92
681–700 73
701–720 57
721–740 54
741–760 67
761–780 45
781–800 46
801–820 39
821–840 32
841–860 36
861–880 29
881–900 26
901–920 24
921–940 14
941–960 23
961–980 28
981–1,000 15
1,001–1,020 29
1,021–1,040 12
1,041–1,060 19
1,061–1,080 12
1,081–1,100 6
1,101–1,120 8
1,121–1,140 12
1,141–1,160 5
1,161–1,180 6
1,181–1,200 14
1,201–1,220 7
1,221–1,240 2
1,241–1,260 6
1,261–1,280 4
1,281–1,294 6
1,295+ 100
Download as CSV

Michael Rowley D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Michael Rowley sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 61 bars. Horizontal axis: D-Index, 40–41 to 159+. Vertical axis: number of scientists, 0 to 1,051. Most scientists, 1,051, have 56–57 D-Index. The last bar groups every scientist with 159 D-Index or more. The highlighted bar, 52–53 D-Index, is where this scientist sits. 40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40–41 D-Index 159+

This scientist: 52 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

View D-Index distribution as a table
Number of Chemistry scientists by D-index, Research.com 2026 ranking edition. Based on 17,934 ranked scientists.
D-Index Scientists This scientist
40–41 289
42–43 612
44–45 808
46–47 776
48–49 835
50–51 861
52–53 872 52
54–55 933
56–57 1,051
58–59 930
60–61 882
62–63 834
64–65 731
66–67 775
68–69 683
70–71 646
72–73 561
74–75 501
76–77 437
78–79 388
80–81 354
82–83 292
84–85 275
86–87 254
88–89 235
90–91 185
92–93 192
94–95 155
96–97 163
98–99 125
100–101 105
102–103 105
104–105 112
106–107 88
108–109 68
110–111 69
112–113 65
114–115 79
116–117 61
118–119 44
120–121 37
122–123 40
124–125 33
126–127 26
128–129 34
130–131 35
132–133 25
134–135 27
136–137 17
138–139 16
140–141 20
142–143 20
144–145 15
146–147 9
148–149 9
150–151 16
152–153 11
154–155 9
156–157 3
158 3
159+ 98
Download as CSV

Overview

Michael Rowley is affiliated with Pharmaron in the United Kingdom and is engaged in medical research primarily within the field of Medicine. Their research spans various subfields, including Surgery, Hepatology, Gastroenterology, Pulmonary and Respiratory Medicine, and Genetics.

Their work covers several scientific topics related to organ transplantation and gastrointestinal health. Key areas of focus include:

  • Organ Transplantation Techniques and Outcomes
  • Liver Disease and Transplantation
  • Gastrointestinal Bleeding Diagnosis and Treatment
  • Cystic Fibrosis Research Advances
  • Transplantation: Methods and Outcomes
  • Vascular Anomalies and Treatments
  • Pancreatic and Hepatic Oncology Research

Michael Rowley has published research in several scientific venues. Frequent publication venues include:

  • International Journal of Management Concepts and Philosophy
  • Gastrointestinal Endoscopy
  • Journal of Cystic Fibrosis
  • Experimental and Clinical Transplantation
  • The American Journal of Gastroenterology

Some of their most recent papers are:

  • Coil migration after EUS-guided coil embolization of gastric varices, 2020, Gastrointestinal Endoscopy
  • 330: Patient valuation of health-related quality of life associated with treatment burden and pulmonary exacerbation in cystic fibrosis, 2021, Journal of Cystic Fibrosis
  • Rapid Development of De Novo Thoracic Aneurysm After Liver Transplant, 2021, Experimental and Clinical Transplantation
  • S0096 Differences in Genomic Mutations in Precancerous Pancreatic Cysts Between African Americans and Caucasians, 2020, The American Journal of Gastroenterology
  • Conceptual Framework for Systematic Problem Solving: A Roadmap for Root Cause Discovery, 2022, International Journal of Management Concepts and Philosophy

Collaborations with other researchers form a part of their work. Frequent co-authors include:

  • Saso Krstovski
  • Jorge Suárez
  • R. Cameron
  • J.G. Matthews
  • Daniel Office

Best Publications

  • Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection

    Vincenzo Summa;Alessia Petrocchi;Fabio Bonelli;Benedetta Crescenzi

  • Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors.

    Philip Jones;Sergio Altamura;Julia Boueres;Federica Ferrigno

  • MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant Variants

    Vincenzo Summa;Steven W. Ludmerer;John A. McCauley;Christine Fandozzi

  • Mechanism of Action and Antiviral Activity of Benzimidazole-Based Allosteric Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase

    Licia Tomei;Sergio Altamura;Linda Bartholomew;Antonino Biroccio

  • Interdomain Communication in Hepatitis C Virus Polymerase Abolished by Small-Molecule Inhibitors Bound to a Novel Allosteric Site

    Stefania Di Marco;Cinzia Volpari;Licia Tomei;Sergio Altamura

  • Fluorination of 3-(3-(Piperidin-1-yl)propyl)indoles and 3-(3-(Piperazin-1-yl)propyl)indoles Gives Selective Human 5-HT1D Receptor Ligands with Improved Pharmacokinetic Profiles

    M. B. Van Niel;I. Collins;M. S. Beer;H. B. Broughton

  • Niraparib: A Poly(ADP-ribose) Polymerase (PARP) Inhibitor for the Treatment of Tumors with Defective Homologous Recombination.

    Philip Jones;Keith Wilcoxen;Michael Rowley;Carlo Toniatti

  • Current and novel approaches to the drug treatment of schizophrenia.

    Michael Rowley;Linda J. Bristow;Peter H. Hutson

  • Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor.

    Steven Harper;John A McCauley;Michael T Rudd;Marco Ferrara

  • Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonists.

    Michael Rowley;Janusz J. Kulagowski;Alan P. Watt;Denise Rathbone

  • 3'-(Arylmethyl)- and 3'-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones : orally active antagonists of the glycine site on the NMDA receptor

    Kulagowski Jj;Baker R;Curtis Nr;Leeson Pd

  • 4,5-dihydroxypyrimidine carboxamides and N-alkyl-5-hydroxypyrimidinone carboxamides are potent, selective HIV integrase inhibitors with good pharmacokinetic profiles in preclinical species.

    Vincenzo Summa;Alessia Petrocchi;Victor G. Matassa;Cristina Gardelli

  • Total synthesis of (+)-ophiobolin C

    Michael Rowley;Masamitsu Tsukamoto;Yoshito Kishi

  • 3-Heteroaryl-2-pyridones: benzodiazepine site ligands with functional delectivity for alpha 2/alpha 3-subtypes of human GABA(A) receptor-ion channels

    Ian Collins;Christopher Moyes;William B Davey;Michael Rowley

  • 5-(4-Chlorophenyl)-4-methyl-3-(1-(2-phenylethyl)piperidin-4-yl)isoxazole: a potent, selective antagonist at human cloned dopamine D4 receptors.

    Rowley M;Broughton Hb;Collins I;Baker R

  • 3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists.

    M Rowley;D J Hallett;S Goodacre;C Moyes

  • Tetrazole thioacetanilides: potent non-nucleoside inhibitors of WT HIV reverse transcriptase and its K103N mutant.

    Ester Muraglia;Olaf D. Kinzel;Ralph Laufer;Michael D. Miller

  • 3-Acyl-4-hydroxyquinolin-2(1H)-ones. Systemically active anticonvulsants acting by antagonism at the glycine site of the N-methyl-D-aspartate receptor complex.

    Rowley M;Leeson Pd;Stevenson Gi;Moseley Am

  • Dihydroxypyrimidine-4-carboxamides as novel potent and selective HIV integrase inhibitors.

    Paola Pace;M. Emilia Di Francesco;Cristina Gardelli;Steven Harper

  • Potent inhibitors of subgenomic hepatitis C virus RNA replication through optimization of indole-N-acetamide allosteric inhibitors of the viral NS5B polymerase.

    Steven Harper;Salvatore Avolio;Barbara Pacini;Marcello Di Filippo

Frequent Co-Authors

Paul D. Leeson
Paul D. Leeson Loughborough University
Ian Collins
Ian Collins PharmEnable Therapeutics
Raymond Baker
Raymond Baker MSD (United States)
Raffaele De Francesco
Raffaele De Francesco University of Milan
Carlo Toniatti
Carlo Toniatti The University of Texas MD Anderson Cancer Center
David B. Olsen
David B. Olsen MSD (United States)
Daria J. Hazuda
Daria J. Hazuda MSD (United States)
Joseph P. Vacca
Joseph P. Vacca MSD (United States)
Andrea Carfi
Andrea Carfi Novartis (Switzerland)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students pursuing Chemistry in the USA, exploring related fields can open diverse career options, especially in forensic science. Many professionals combine their chemistry knowledge with forensic applications, benefiting from specialized online courses. Programs like online forensic science courses provide a flexible pathway to gain expertise in crime lab techniques, toxicology, and evidence analysis.

Advancing your education with an online master’s in forensic psychology can also complement a chemistry background, particularly for those interested in the psychological aspects behind criminal behavior. This degree enhances one’s ability to work at the intersection of science and law enforcement.

Career opportunities in forensic science are broad and growing, ranging from crime scene investigation to toxicology and beyond. For those curious about the different paths available, the forensic science career overview highlights roles that leverage scientific skills developed in chemistry studies.

Individuals considering technical roles may find the autopsy tech salary and job outlook information helpful. Autopsy technicians apply chemical knowledge in pathology settings, offering a stable and rewarding career path.

Best Scientists Citing Michael Rowley

Trending Scientists

Recently Published Articles